Johnson & Johnson competitorsClear all

Boston Scientific's top competitors include GSK, Estee Lauder, Merck Group, Henkel, Medtronic, Essity, Bristol-Myers Squibb, Roche, Abbott, Merck and Novartis.
Boston Scientific
Boston Scientific
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices.
GSK
GSK
GSK (GlaxoSmithKline) is a science-led healthcare company.
Estee Lauder
Estee Lauder
The Estée Lauder Companies is a manufacturer and marketer of skincare, makeup, fragrance, and hair care products.
Merck Group
Merck Group
Merck Group is a pharmaceutical, chemical, and life sciences company.
Henkel
Henkel
Henkel is a company engaged in laundry and home care, beauty care, and adhesive technology businesses.
Medtronic
Medtronic
Medtronic is a company that develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients.
Essity
Essity
Essity is a company providing personal care, consumer tissue, and professional hygiene products.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with serious and life-threatening diseases.
Roche
Roche
Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.
Abbott
Abbott
Abbott is a healthcare company specializing in diagnostics, medical devices, nutritionals, and branded generic medicines.
Merck
Merck
Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Founding Date
Founding Date
1979
Founding Date
2000
Founding Date
1946
Founding Date
1668
Founding Date
1876
Founding Date
1949
Founding Date
2017
Founding Date
1887
Founding Date
1896
Founding Date
1888
Founding Date
1891
Founding Date
1996
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Marlborough, US HQ
Shanghai, CN
Coyol, CR
La Aurora, CR
Villepinte, FR
Voisins Le Bretonneux, FR
see more
Locations
Brentford, GB HQ
Boudouaou, DZ
San Fernando, AR
Abbotsford, AU
Boronia, AU
Ermington, AU
Wien, AT
see more
Locations
New York, US HQ
Buenos Aires, AR
Erskineville, AU
Wien, AT
Machelen, BE
Toronto, CA
see more
Locations
Darmstadt, DE HQ
Hydra, DZ
Csd, AR
Bayswater, AU
Bayswater, AU
Macquarie Park, AU
Wien, AT
see more
Locations
Düsseldorf, DE HQ
Dely Ibrahim, DZ
Chivilcoy, AR
San Isidro, AR
Frenchs Forest, AU
Ingleburn, AU
Kilsyth, AU
see more
Locations
Dublin, IE HQ
North Ryde, AU
Wien, AT
Jette, BE
São Paulo, BR
Brampton, CA
Kirkland, CA
see more
Locations
Stockholm, SE HQ
Annaba, DZ
Buenos Aires, AR
Kingsgrove, AU
Pernitz, AT
Wien, AT
Verviers, BE
see more
Locations
New York, US HQ
Braine L'alleud, BE
Watermaal Bosvoorde, BE
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
see more
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Wien, AT
see more
Locations
Lake Bluff, US HQ
Tiranë, AL
Buenos Aires, AR
Yerevan, AM
Doncaster, AU
Macquarie Park, AU
Melbourne, AU
see more
Locations
Kenilworth, US HQ
Hydra, DZ
Munro, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
Manama, BH
see more
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Employees
Employees
36,00013% increase
Employees
99,4374% increase
Employees
48,000
Employees
58,1272% increase
Employees
52,9501% increase
Employees
90,000
Employees
46,000
Employees
30,00029% increase
Employees
97,735
Employees
107,0004% increase
Employees
71,0003% increase
Employees
105,7942% increase
Valuation ($)
Valuation ($)
61.3 b
Valuation ($)
95.5 b
Valuation ($)
110 b
Valuation ($)
75.1 b
Valuation ($)
46.6 b
Valuation ($)
170.8 b
Valuation ($)
24.3 b
Valuation ($)
143.9 b
Valuation ($)
N/A
Valuation ($)
210.7 b
Valuation ($)
198.5 b
Valuation ($)
N/A
Twitter followers
Twitter followers
34.9 k
Twitter followers
222.6 k
Twitter followers
138
Twitter followers
20.7 k
Twitter followers
20.9 k
Twitter followers
77.4 k
Twitter followers
11 k
Twitter followers
152 k
Twitter followers
231.7 k
Twitter followers
107 k
Twitter followers
208.3 k
Twitter followers
292.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
69
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
92
Number of tweets (last 30 days)
63
Number of tweets (last 30 days)
51
Number of tweets (last 30 days)
34
Number of tweets (last 30 days)
60
Number of tweets (last 30 days)
63
Number of tweets (last 30 days)
219
Number of tweets (last 30 days)
34
Number of tweets (last 30 days)
21
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
12.1
Average likes per tweet (last 30 days)
15.4
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.2
Average likes per tweet (last 30 days)
6.5
Average likes per tweet (last 30 days)
11.8
Average likes per tweet (last 30 days)
5.2
Average likes per tweet (last 30 days)
8
Average likes per tweet (last 30 days)
9.3
Average likes per tweet (last 30 days)
11.6
Average likes per tweet (last 30 days)
18.3
Average likes per tweet (last 30 days)
9.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
93.75%
Percentage of tweets with engagement (last 30 days)
91.3%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
89.13%
Percentage of tweets with engagement (last 30 days)
80.95%
Percentage of tweets with engagement (last 30 days)
56.86%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
73.02%
Percentage of tweets with engagement (last 30 days)
57.53%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
57.14%
Alexa Website Rank
Alexa Website Rank
172278
Alexa Website Rank
58088
Alexa Website Rank
104836
Alexa Website Rank
150790
Alexa Website Rank
195159
Alexa Website Rank
56576
Alexa Website Rank
300505
Alexa Website Rank
101235
Alexa Website Rank
45834
Alexa Website Rank
42367
Alexa Website Rank
56943
Alexa Website Rank
88970
Employee Rating
Employee Rating
4.3
Employee Rating
3.8
Employee Rating
N/A
Employee Rating
4
Employee Rating
4.3
Employee Rating
4
Employee Rating
4.1
Employee Rating
4.1
Employee Rating
N/A
Employee Rating
3.9
Employee Rating
4.2
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
$10.7b (FY, 2019)
Revenue (est.)
£33.8b (FY, 2019)
Revenue (est.)
$14.3b (FY, 2020)
Revenue (est.)
€17.5b (FY, 2020)
Revenue (est.)
€20.1b (FY, 2019)
Revenue (est.)
$28.9b (FY, 2020)
Revenue (est.)
kr129b (FY, 2019)
Revenue (est.)
$42.5b (FY, 2020)
Revenue (est.)
CHF63.8b (FY, 2019)
Revenue (est.)
$34.6b (FY, 2020)
Revenue (est.)
$48b (FY, 2020)
Revenue (est.)
$48.7b (FY, 2020)
Cost of goods
Cost of goods
$3.1b (FY, 2019)
Cost of goods
£11.9b (FY, 2019)
Cost of goods
$3.6b (FY, 2020)
Cost of goods
€6.8b (FY, 2020)
Cost of goods
€10.9b (FY, 2019)
Cost of goods
$9.4b (FY, 2020)
Cost of goods
kr90.9b (FY, 2019)
Cost of goods
$11.8b (FY, 2020)
Cost of goods
CHF18.4b (FY, 2019)
Cost of goods
$15b (FY, 2020)
Cost of goods
$15.5b (FY, 2020)
Cost of goods
$15.1b (FY, 2020)
Gross profit
Gross profit
$7.6b (FY, 2019)
Gross profit
£21.9b (FY, 2019)
Gross profit
$10.7b (FY, 2020)
Gross profit
€10.7b (FY, 2020)
Gross profit
€9.2b (FY, 2019)
Gross profit
$19.5b (FY, 2020)
Gross profit
kr38.1b (FY, 2019)
Gross profit
$30.7b (FY, 2020)
Gross profit
CHF45.4b (FY, 2019)
Gross profit
$19.6b (FY, 2020)
Gross profit
$32.5b (FY, 2020)
Gross profit
$33.5b (FY, 2020)
Net income
Net income
$4.7b (FY, 2019)
Net income
£5.3b (FY, 2019)
Net income
$696m (FY, 2020)
Net income
€2b (FY, 2020)
Net income
€2.1b (FY, 2019)
Net income
$4.8b (FY, 2020)
Net income
kr10.2b (FY, 2019)
Net income
($9b) (FY, 2020)
Net income
CHF14.1b (FY, 2019)
Net income
$4.5b (FY, 2020)
Net income
$7.1b (FY, 2020)
Net income
$8.1b (FY, 2020)

Operating

Countries
Countries
120 (FY, 2019)
Countries
N/A
Countries
150 (FY, 2020)
Countries
66 (FY, 2020)
Countries
N/A
Countries
150 (FY, 2020)
Countries
150 (FY, 2019)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries (Manufacturing Sites)
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
56 (FY, 2019)
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
32 (FY, 2017)
Countries (Manufacturing Sites)
N/A
Countries (Manufacturing Sites)
N/A
Manufacturing Facilities
Manufacturing Facilities
16 (FY, 2019)
Manufacturing Facilities
87 (FY, 2016)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
89 (FY, 2016)
Manufacturing Facilities
90 (FY, 2019)
Manufacturing Facilities
7 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Sites
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
23 (FY, 2019)
Manufacturing Sites
92 (FY, 2019)
Manufacturing Sites
N/A
Manufacturing Sites
N/A
New Product Launches
New Product Launches
N/A
New Product Launches
30 (FY, 2016)
New Product Launches
N/A
New Product Launches
N/A
New Product Launches
N/A
New Product Launches
N/A
New Product Launches
N/A
New Product Launches
N/A
New Product Launches
N/A
New Product Launches
25 (FY, 2018)
New Product Launches
N/A
New Product Launches
N/A
Patents Issued
Patents Issued
21 k (FY, 2019)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
9.3 k (FY, 2019)
Patents Issued
N/A
Patents Issued
457 (Jun, 2020)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Phase I Trials Products (Immunology)
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
5 (FY, 2019)
Phase I Trials Products (Immunology)
7 (Dec, 2020)
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
19 (FY, 2019)
Phase I Trials Products (Oncology)
43 (Dec, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products (Immunology)
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
4 (FY, 2019)
Phase II Trials Products (Immunology)
9 (Dec, 2020)
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
14 (FY, 2019)
Phase II Trials Products (Oncology)
7 (Dec, 2020)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
14 (FY, 2019)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
25 (Nov, 2020)
Phase III Trials Products
44 (Q4, 2020)
Phase III Trials Products (Immunology)
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
4 (FY, 2019)
Phase III Trials Products (Immunology)
7 (Dec, 2020)
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
9 (FY, 2019)
Phase III Trials Products (Oncology)
26 (Dec, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
22 (Q4, 2020)
Products
Products
N/A
Products
N/A
Products
N/A
Products
300 k (FY, 2020)
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
1.5 k (FY, 2019)
Products
102 (Nov, 2020)
Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
10 (May, 2018)
Projects in R&D Pipeline
N/A
Research and Development Centers
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
24 (FY, 2019)
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
12 (FY, 2019)
Research and Development Centers
29 (FY, 2019)
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
4 (FY, 2019)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
6 (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 337m
Total funding raised
$ 330.2m
Total funding raised
$ 15.5m
Total funding raised
$ 2.8b
Total funding raised
$ 6.9m
Total funding raised
$ 5.6m
Total funding raised
$ 6.5m
For sources of this data, please see the company profile

View company profiles

GSK
HQ
Brentford, GB
Employees
99,437↑ 4% increase

GSK (GlaxoSmithKline) is a science-led healthcare company.

View company
Estee Lauder
HQ
New York, US
Employees
48,000

The Estée Lauder Companies is a manufacturer and marketer of skincare, makeup, fragrance, and hair care products.

View company
Merck Group
HQ
Darmstadt, DE
Employees
58,127↑ 2% increase

Merck Group is a pharmaceutical, chemical, and life sciences company.

View company
Henkel
HQ
Düsseldorf, DE
Employees
52,950↑ 1% increase

Henkel is a company engaged in laundry and home care, beauty care, and adhesive technology businesses.

View company